Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2022 | An overview on late-stage Parkinson’s disease

Margherita Fabbri, MD, PhD, University of Toulouse, Toulouse, France, describes challenges associated with late-stage Parkinson’s disease (PD). The clinical presentation in late-stage PD is characterized by a worsening of motor and non-motor symptoms such as postural instability and cognitive impairment. Patients with late-stage PD are highly dependent on activities of daily living and require significant medical needs. However, due to the advanced stage of the disease, these patients have not been included in clinical trials. Still, efforts are underway to start including patients with late-stage PD in pharmacological and non-pharmacological studies and, therefore, help improve treatment strategies for those patients. Dr Fabbri highlights the importance of providing multidisciplinary care to late-stage PD patients, mainly using a model that could reach patients at home or in institutions. Considering those needs, the PD_Pal project was developed to validate a new model of palliative care for people with PD. This interview took place at the 2022 International Congress of Parkinson’s disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.